Hedge Fund - Baker Bros. Advisors
Summit Therapeutics Inc. ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $435,861,716 | 4.65% | 24,424,865 | $ |
| 2 | 2024 - Q3 (2024-09-30) | $534,904,544 | 5.54% | 24,424,865 | $ |
| 3 | 2024 - Q2 (2024-06-30) | $181,133,332 | 2.31% | 23,222,222 | $ |
| 4 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $ |
| 5 | 2023 - Q3 (2023-09-30) | $5,872,685 | 0.03% | 3,140,473 | $ |
| 6 | 2023 - Q2 (2023-06-30) | $15,824,810 | 0.09% | 6,304,705 | $ |
| 7 | 2023 - Q1 (2023-03-31) | $11,033,234 | 0.06% | 6,304,705 | $ |
| 8 | 2022 - Q4 (2022-12-31) | $8,500,000 | 0.05% | 2,000,000 | $ |
The displayed share prices are average quarterly stock market prices.